Quality & complianceOfficial

Denmark flags Avipro IBD V217 poultry vaccine shortage linked to higher demand

🇩🇰 DKMA · Thu 05 Nov 2026

The Danish Medicines Agency says Elanco's live infectious bursal disease vaccine for drinking water is in short supply, with disruption expected from mid-September to mid-December 2026.

The Danish Medicines Agency (DKMA) has published a supply-disruption notice for Avipro IBD V217, a lyophilisate for use in drinking water marketed in Denmark by Elanco Denmark ApS. The notice was first posted on 21 September 2026 and updated on 5 November 2026.

The product is a veterinary vaccine containing live infectious bursal disease virus, strain V217, and carries the ATC vet code QI01AD09. DKMA gives the expected period of disruption as mid-September to mid-December 2026.

The agency attributes the problem to increased sales and demand. The notice does not describe any quality defect or safety concern, and it does not name alternative products or say how users should manage the gap.

DKMA directs anyone seeking the current status to contact the company, and the notice sits within its wider listing of medicine supply announcements.

What it means for your team

  • Veterinary supply and market-access teams in Denmark should check the stated mid-September to mid-December 2026 window against their stock and ordering plans.
  • The stated cause is higher demand, not a quality or safety issue, so no pharmacovigilance action is indicated by the notice.
  • The notice names no alternatives, so questions about availability should go directly to Elanco Denmark ApS.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →